132 related articles for article (PubMed ID: 14982561)
1. Altered brain exposure of morphine in experimental meningitis studied with microdialysis.
Tunblad K; Ederoth P; Gärdenfors A; Hammarlund-Udenaes M; Nordström CH
Acta Anaesthesiol Scand; 2004 Mar; 48(3):294-301. PubMed ID: 14982561
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier transport of morphine in patients with severe brain trauma.
Ederoth P; Tunblad K; Bouw R; Lundberg CJ; Ungerstedt U; Nordström CH; Hammarlund-Udenaes M
Br J Clin Pharmacol; 2004 Apr; 57(4):427-35. PubMed ID: 15025740
[TBL] [Abstract][Full Text] [Related]
3. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
[TBL] [Abstract][Full Text] [Related]
4. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
Boström E; Hammarlund-Udenaes M; Simonsson US
Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
[TBL] [Abstract][Full Text] [Related]
6. Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis.
Bouw R; Ederoth P; Lundberg J; Ungerstedt U; Nordström CH; Hammarlund-Udenaes M
Acta Anaesthesiol Scand; 2001 Mar; 45(3):390-2. PubMed ID: 11207479
[TBL] [Abstract][Full Text] [Related]
7. A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: potential involvement of a carrier-mediated mechanism.
Au-Yeung SC; Rurak DW; Gruber N; Riggs KW
Drug Metab Dispos; 2006 Jun; 34(6):955-60. PubMed ID: 16510542
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):701-12. PubMed ID: 17471182
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study.
Bouw MR; Gårdmark M; Hammarlund-Udenaes M
Pharm Res; 2000 Oct; 17(10):1220-7. PubMed ID: 11145227
[TBL] [Abstract][Full Text] [Related]
10. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
Bourasset F; Bernard K; Muñoz C; Genissel P; Scherrmann JM
Drug Metab Dispos; 2005 Aug; 33(8):1137-43. PubMed ID: 15860654
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice.
Boix F; Andersen JM; Mørland J
Addict Biol; 2013 Jan; 18(1):1-7. PubMed ID: 21481103
[TBL] [Abstract][Full Text] [Related]
12. Morphine blood-brain barrier transport is influenced by probenecid co-administration.
Tunblad K; Jonsson EN; Hammarlund-Udenaes M
Pharm Res; 2003 Apr; 20(4):618-23. PubMed ID: 12739770
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of blood-brain barrier damage during microdialysis.
Morgan ME; Singhal D; Anderson BD
J Pharmacol Exp Ther; 1996 May; 277(2):1167-76. PubMed ID: 8627529
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
Bundgaard C; Jørgensen M; Larsen F
Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical monitoring using intracerebral microdialysis during systemic haemorrhage.
Meybohm P; Cavus E; Bein B; Steinfath M; Weber B; Scholz J; Doerges V
Acta Neurochir (Wien); 2007; 149(7):691-8. PubMed ID: 17594051
[TBL] [Abstract][Full Text] [Related]
16. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: an in vivo microdialysis study.
Song Y; Feng Y; Leblanc MH; Castagloni N; Liu YM
Neurosci Lett; 2006 Feb; 395(1):63-6. PubMed ID: 16289318
[TBL] [Abstract][Full Text] [Related]
17. Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).
Gupta A; Chatelain P; Massingham R; Jonsson EN; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Feb; 34(2):318-23. PubMed ID: 16303872
[TBL] [Abstract][Full Text] [Related]
18. Morphine perfused rabbits: a tool for experiments in forensic entomotoxicology.
Hédouin V; Bourel B; Martin-Bouyer L; Bécart A; Tournel G; Deveaux M; Gosset D
J Forensic Sci; 1999 Mar; 44(2):347-50. PubMed ID: 10097360
[TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide.
Bourasset F; Scherrmann JM
Life Sci; 2006 Apr; 78(20):2302-14. PubMed ID: 16309712
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of morphine-induced neuronal nitric oxide production and antinociceptive tolerance development.
Heinzen EL; Pollack GM
Brain Res; 2004 Oct; 1023(2):175-84. PubMed ID: 15374743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]